TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative products for the treatment of rare genetic diseases ...
Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.
CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative ...
SOUTH PLAINFIELD, N.J., Jan. 22, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), the SMA Foundation, and Roche (SIX: RO, ROG; OTCQX: RHHBY), announced ...
Medical Device Network on MSN
Biogen acquires Alcyone to boost CNS drug delivery
ThecaFlex DRx is an implantable device designed to improve treatment options for patients with neurological disorders.
NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals, LLC (Marathon), a U.S. research-based biopharmaceutical company focused solely on the development of new treatments for rare diseases, ...
Following months of rumors, leaks, and a mountain of speculation, Apple earlier this week finally unveiled its next generation iPhone devices, the iPhone 8 and iPhone 8 Plus, and iPhone X (pronounced ...
Innovation Passport award facilitates accelerated time to market and helps expedite patient access to transformative new medicines - - New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback